Botox vs fillers: what is the difference and which do you need?

Botox (onabotulinumtoxinA, Allergan/AbbVie) is an injectable botulinum toxin medicine.

Its FDA label covers four cosmetic uses in adults: moderate to severe frown lines, crow's feet, forehead lines and platysma bands — the vertical neck bands.

No other cosmetic area is on the label.

It works in muscle: the toxin blocks acetylcholine release at nerve endings, producing a partial, localized reduction in muscle activity that reinnervation slowly reverses.

Our Botox guide covers each approved area in detail.

Dermal fillers sit in a different regulatory category: FDA regulates them as medical device implants, not drugs.

Fillers are approved for adults over 21 for specific uses, such as moderate to severe facial wrinkles and folds and augmentation of the lips, cheeks, chin and back of the hand. Juvederm is one filler family made by Allergan; the dermal fillers guide maps the rest.

Both categories dominate minimally invasive aesthetics: ASPS's 2025 Procedural Statistics report says neuromodulator injections accounted for about half of all minimally invasive procedures performed in 2025, with hyaluronic acid fillers another 30%.

Here is the side-by-side version; the sections below take the points in turn.

Onset is where the sources are lopsided.

The Botox Cosmetic label describes muscle relaxation in the frown-line area beginning 1 to 2 days after injection and increasing in intensity during the first week, and the American Academy of Dermatology says most people see results within 3 to 7 days.

Our sources give no comparable onset figure for fillers, so ask the practice what to expect from the specific product.

"Spread" also means different things for the two.

The toxin risk that carries FDA's boxed warning is distant spread of toxin effect — the boxed warning above.

For fillers, the agency's most concerning risk is different: unintentional injection into a blood vessel.

The two products are priced on different scales.

Botox and other toxins are typically priced per unit or per treatment area, and the label doses give a unit floor per area — 20 units for frown lines, 24 for crow's feet, 40 for forehead lines treated together with frown lines — so an area's price is roughly its units times the practice's per-unit price.

Our Botox cost guide unpacks how those quotes are built.

For fillers, the national figure our sources carry is ASPS's own cost page, which lists average costs of $715 for hyaluronic acid fillers, $901 for non-HA fillers such as Radiesse and Sculptra, and $743 for lip augmentation with filler.

Those are average fees reported by ASPS member plastic surgeons, not med spa prices, and the page states no data year.

On the toxin side there is no matching figure in our sources: ASPS's 2025 statistics release publishes no average fees for minimally invasive treatments.

One chain's published prices show how the two structures sit side by side: LaserAway listed Botox at $15 per unit, or $10 per unit in a 300-unit bank, and Juvéderm lips at $450 per full syringe, face $450–$900 and cheeks $750–$1,500 per treatment (its site, read October 16, 2026, at its locations).

Those are one chain's prices, not national averages — and a per-unit toxin quote and a per-syringe filler quote are different units, so they do not reduce to a single "which is cheaper." The dermal filler cost guide covers the syringe side in depth.

Cleveland Clinic's framing is the useful one: Botox treats dynamic wrinkles — lines that appear when a muscle contracts, such as when frowning or smiling — and patients whose wrinkles are present and deep at rest may benefit from adding a filler in addition to Botox.

By area, the labels draw the map.

Botox Cosmetic's four approved areas are frown lines, crow's feet, forehead lines and platysma neck bands.

Fillers are approved for moderate to severe facial wrinkles and folds and for augmentation of the lips, cheeks, chin and back of the hand in adults over 21.

Lips show the difference in miniature: a lip flip — an off-label toxin use, since no US neurotoxin label includes the lips — does not add volume; it everts (rolls out) the upper lip by relaxing the orbicularis oris, whereas lip filler adds volume.

We compare the two directly in lip flip vs lip filler.

Which one your line needs is a judgment for the licensed provider who examines you: this page can only set out what each product is approved for, not tell you what to get.

Not the way you switch between two brands of the same thing: a muscle relaxant and a volume implant do different jobs, so the real question is which one your line calls for — or whether to use both, which the next sections take up.

If by "switch" you mean moving between botulinum toxin brands — Botox to Dysport, say — the Botox Cosmetic label says the effect of giving different botulinum toxin products at the same time or within several months of each other is unknown, and that excessive weakness may be worsened by giving another toxin before a previous one wears off.

That toxin-vs-toxin comparison lives in Botox vs Dysport, and all neurotoxin brands are compared on one page.

Absorbable fillers are not permanent either: FDA describes them as temporary and says patients may need to repeat the procedure after some time to maintain the effect.

Start from the regulators' baseline.

FDA says filler injection should be considered a medical procedure, and advises against buying dermal fillers online because products sold that way could be counterfeit or unapproved.

CDC advises getting botulinum toxin only from a licensed, trained provider using product from an authorized source — and cautions that even FDA-approved product, given correctly, still carries some risk.

Who may inject is regulated state by state: AmSpa's position is that injecting botulinum toxin is the practice of medicine, so it must be done by a physician, an independent-practice NP or another licensed professional acting within their scope, under rules that vary by state.

FDA's advice for filler patients is to choose a licensed provider experienced in dermatology or plastic surgery and trained to inject fillers, who uses properly labeled, sealed vials or pre-filled syringes of FDA-approved filler.

Before you book any practice, ask:

Botox changes muscle pull.

It blocks acetylcholine release at nerve endings, producing a partial, localized reduction in muscle activity; as reinnervation slowly reverses the effect, the muscle regains its signal and the improvement wears off.

In the mirror, that shows up as a softened line when you frown or squint — the dynamic wrinkles Cleveland Clinic describes.

A filler changes volume.

It is a medical device implant placed under the skin to create a smoother or fuller appearance — filling a fold such as the nasolabial fold, or augmenting the lips, cheeks, chin or the back of the hand.

So neither is "better" in the abstract: one quiets a muscle, the other occupies space.

The question that decides it is which change the line in front of you actually needs, which is what an in-person examination is for.

For lines that show with movement, the toxin is the product with label coverage: frown lines, crow's feet and forehead lines are three of Botox Cosmetic's four approved areas, and the fourth is the vertical neck bands.

FDA describes fillers, meanwhile, as approved to create a smoother and/or fuller appearance in the face, including the nasolabial folds, cheeks, chin, lips and back of the hands.

Cleveland Clinic's at-rest test is the practical divider: a line that deepens when you frown and fades when your face relaxes is the pattern a toxin addresses, while wrinkles that are present and deep even at rest are the pattern Cleveland Clinic says may benefit from adding a filler in addition to Botox.

Our wrinkle treatments guide maps individual lines to the treatments aimed at them, and a licensed provider can tell which pattern your lines follow after examining the muscle movement in person.

Combining the two is an idea clinic patient material describes: Cleveland Clinic says patients whose wrinkles are deep even at rest may benefit from a filler in addition to Botox.

On doing both in a single visit, the sources for this guide give no rule we can cite — we could not confirm a label or FDA statement on same-day scheduling — so treat it as a question for the practice: whether they combine them, in which order, and why for your areas.

If you do have both, remember that the two risk profiles travel separately: the toxin's boxed warning for distant spread of toxin effect applies to the Botox portion, and FDA's most concerning filler risk — unintentional injection into a blood vessel — applies to the filler portion.

Botox's label gives 3 to 4 months for frown lines — the only cosmetic area with a duration statement on the Botox Cosmetic label — and the American Academy of Dermatology gives the same range and adds that improvements sometimes last longer.

The label adds that the safety and effectiveness of dosing more often than every 3 months have not been clinically evaluated.

Fillers come with a different kind of answer.

FDA says how long a filler lasts depends on the filler material and where it is injected, and that absorbable fillers are temporary and may need repeat treatment.

Allergan says two of its Juvéderm lip products, Volbella XC and Ultra XC, can last up to 1 year in the lips with optimal treatment — a manufacturer's "up to" figure, not a typical result.

So the durations do not line up cleanly: one label number with a narrow scope on the toxin side, material- and site-specific figures on the filler side.

Ask the practice how long the specific product, in the specific area, is expected to hold.